Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03086421 : Social Emotional Development in Young Children With Cancer
PhaseN/A
AgesMin: 4 Years Max: 6 Years
Eligibility
Inclusion Criteria:

- Primary Diagnosis of a brain or non-CNS solid tumor

- Between 4 and 6 years of age at enrollment

- Between 6 and 12 months post-therapy at the time of enrollment

- Treatment plan included chemotherapy

- English speaking

- Cognitive and language capacity to complete measures

Exclusion Criteria:

- Diagnosis of advanced disease, defined as M+ status in children with brain tumors and
Stage 4 in children with solid tumors.

- Diagnosis of a genetic disorder/pre-existing neurodevelopmental condition associated
with neurocognitive or social impairment (e.g., autism, Neurofibromatosis Type 1
(NF1), Down syndrome)

- Solid tumor patients who required CNS-directed therapy (e.g., radiation, intrathecal
chemotherapy)

- Inability or unwillingness of research participant or legal guardian/representative
to give written informed consent.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT03086421      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740